Santen Pharmaceutical Co Ltd's ticker is SNPHY and the CUSIP is 80287P100. A total of 2 filers reported holding Santen Pharmaceutical Co Ltd in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $19,753,000 | -23.0% | 1,423,119 | -9.8% | 0.01% | -31.2% |
| Q4 2020 | $25,659,000 | -19.5% | 1,577,090 | +1.7% | 0.02% | -30.4% |
| Q3 2020 | $31,877,000 | +9.9% | 1,551,171 | -1.4% | 0.02% | +4.5% |
| Q2 2020 | $28,993,000 | +27.0% | 1,573,987 | +17.1% | 0.02% | +4.8% |
| Q1 2020 | $22,830,000 | -8.6% | 1,343,749 | +2.5% | 0.02% | +16.7% |
| Q4 2019 | $24,979,000 | +15.3% | 1,310,872 | +5.0% | 0.02% | +5.9% |
| Q3 2019 | $21,664,000 | +11.7% | 1,247,902 | +6.1% | 0.02% | +6.2% |
| Q2 2019 | $19,393,000 | +41.6% | 1,176,056 | +28.1% | 0.02% | +33.3% |
| Q1 2019 | $13,691,000 | -7.3% | 917,927 | -11.2% | 0.01% | -20.0% |
| Q4 2018 | $14,774,000 | -1.9% | 1,033,512 | +8.6% | 0.02% | +15.4% |
| Q3 2018 | $15,061,000 | -15.7% | 951,708 | -7.2% | 0.01% | -23.5% |
| Q2 2018 | $17,873,000 | +7.6% | 1,025,437 | +3.7% | 0.02% | +6.2% |
| Q1 2018 | $16,605,000 | +17.3% | 989,257 | +9.6% | 0.02% | +14.3% |
| Q4 2017 | $14,160,000 | +10.6% | 902,477 | +11.1% | 0.01% | 0.0% |
| Q3 2017 | $12,799,000 | +36.4% | 812,628 | +17.3% | 0.01% | +27.3% |
| Q2 2017 | $9,384,000 | -0.8% | 693,030 | +6.2% | 0.01% | -21.4% |
| Q1 2017 | $9,455,000 | +88.0% | 652,525 | +58.7% | 0.01% | +100.0% |
| Q4 2016 | $5,030,000 | -25.1% | 411,257 | -10.0% | 0.01% | -30.0% |
| Q3 2016 | $6,718,000 | +1.0% | 456,849 | +7.4% | 0.01% | 0.0% |
| Q2 2016 | $6,650,000 | +20.9% | 425,481 | +16.2% | 0.01% | +11.1% |
| Q1 2016 | $5,501,000 | +11.4% | 366,235 | +22.3% | 0.01% | +12.5% |
| Q4 2015 | $4,936,000 | +108.1% | 299,352 | +78.2% | 0.01% | +60.0% |
| Q2 2015 | $2,372,000 | +1.6% | 167,944 | +161.5% | 0.01% | 0.0% |
| Q1 2015 | $2,335,000 | +45.5% | 64,228 | +7.0% | 0.01% | +66.7% |
| Q4 2014 | $1,605,000 | -0.7% | 60,048 | +3.6% | 0.00% | -25.0% |
| Q3 2014 | $1,616,000 | -4.0% | 57,979 | -3.3% | 0.00% | 0.0% |
| Q2 2014 | $1,684,000 | – | 59,976 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 411,257 | $5,030,000 | 0.01% |
| QUADRANT CAPITAL GROUP LLC | 592 | $5,000 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 238 | $3,000 | 0.00% |
| AMERIPRISE FINANCIAL INC | 34,842 | $427,000 | 0.00% |
| GLENMEDE TRUST CO NA | 706 | $8,000 | 0.00% |